Published

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Translational Psychiatry
Date: 2026-06-23
Source: OpenAlex
DOI: 10.1038/s41398-026-04203-2
PubMed: 42342649

Authors

Mauro Pettorruso Giacomo d’Andrea Antonio Inserra Clara Cavallotto Stefano Censi Étienne Billard Antonio Di Stefano Luisa De Risio Maria Giulia Tullo Claudio D’Addario Giorgio Di Lorenzo Richard G. Wise Stefano L. Sensi Francesca Zoratto Giovanni Martinotti

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Chronic Pain Pharmacology Mechanism of Action Receptor Pharmacology Default Mode Network Consciousness Personality Change Mystical Experience Clinical Trial Animal Study Toxicity Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care2026-06-23

Related papers

From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28 Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24